Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Columbia Financial, Inc. (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank. Through these filings, investors can review detailed disclosures on the company’s financial condition, results of operations, capital management, and significant corporate events.
Columbia Financial, Inc. uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered quarterly earnings releases, including financial results for periods ended March 31, June 30, and September 30, as well as the year ended December 31. These filings typically reference press releases furnished as exhibits that discuss net interest income, interest expense on deposits and borrowings, provision for credit losses, non-interest income and expense, net interest margin, and overall net income or loss.
Other 8-K filings describe corporate actions and governance matters. For example, the company has filed 8-Ks regarding authorization of a stock repurchase program to acquire up to 1,800,000 shares of common stock, including details on regulatory non-objection, permitted repurchase methods, and program terms. Additional 8-Ks disclose executive officer changes, such as the planned end date of employment for a Senior Executive Vice President and Chief Operating Officer, and the availability of investor presentations outlining operating and growth strategies.
Annual reports on Form 10-K and quarterly reports on Form 10-Q, when accessed alongside these current reports, provide comprehensive information on Columbia Financial, Inc.’s loan portfolio composition, deposit base, funding sources, balance sheet repositioning transactions, asset quality metrics, and risk factors. These filings also describe the company’s structure as a Delaware corporation and majority-owned subsidiary of Columbia Bank, MHC, and its role as the holding company for Columbia Bank, a federally chartered savings bank headquartered in Fair Lawn, New Jersey.
Stock Titan’s platform enhances these filings by delivering real-time updates from the SEC’s EDGAR system and AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify important information in 10-K and 10-Q reports, track material events reported on Form 8-K, and review disclosures related to capital actions such as stock repurchase programs. Insider transaction reports on Form 4, where available, can also be monitored to see reported purchases and sales by directors and executive officers.
By combining Columbia Financial, Inc.’s official SEC filings with AI-generated insights, this page helps readers understand how the company describes its performance, strategy, and risk profile in its own regulatory disclosures.
Columbia Financial, Inc. granted Senior Executive Vice President and Head of Consumer Banking Allyson Katz stock options for 21,364 shares at an exercise price of $0.00 per share and 12,574 shares of common stock as an equity award.
The options were issued under the 2019 Equity Incentive Plan and vest in three approximately equal annual installments starting on March 2, 2027. The stock award, held indirectly through “Stock Award V,” is performance-based and, if vesting criteria are met, will vest three years after the grant date on March 2, 2029.
Splaine Thomas Jr reported acquisition or exercise transactions in this Form 4 filing.
Columbia Financial, Inc. reported that EVP and CFO Thomas Splaine Jr received equity compensation on March 2, 2026. He was granted 16,098 stock options and 9,475 shares of common stock at no cost under the 2019 Equity Incentive Plan. The awards vest over multiple years, with some tied to performance goals through March 2, 2029, and others in approximately equal annual installments beginning in 2026 and 2027.
Gibney Dennis E. reported acquisition or exercise transactions in this Form 4 filing.
Columbia Financial, Inc. reported that executive Dennis E. Gibney received new equity awards in the form of stock options and common stock. He was granted 53,033 stock options and 31,213 shares of common stock at no cash cost as part of the company’s 2019 Equity Incentive Plan.
The awards vest over time and are tied in part to performance-based criteria, with some options vesting in three approximately equal annual installments starting on March 2, 2027, and certain stock awards scheduled to vest three years after their grant date if specified performance goals are achieved.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported an acquisition of 100.7424 shares of phantom common stock on February 20, 2026, at $18.44 per share, through the company’s stock-based deferral plan.
According to the disclosure, these phantom stock units were purchased on a non-discretionary basis by the trustee of the bank’s rabbi trust under the Columbia Bank Stock Based Deferral Plan and will be settled in actual shares of stock upon distribution to Kemly. Following this award, his indirect deferral-plan-related common stock balance is 66,923.6689 shares.
Klimowich John reported acquisition or exercise transactions in this Form 4 filing.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported an automatic award of 37.1269 phantom common-stock units at $18.44 per unit under Columbia Bank’s stock-based deferral plan. These units are held in a rabbi trust and will be settled in shares to him later. The filing also updates his various direct and indirect holdings of common stock and stock options granted under the 2019 Equity Incentive Plan.
Columbia Financial, Inc. reported that director Paul Van Ostenbridge plans to retire from the Boards of both the Company and its wholly owned subsidiary, Columbia Bank. His retirement will take effect when his current term ends at the Company’s 2026 annual meeting of shareholders.
The Company stated that Mr. Van Ostenbridge’s decision to retire is not due to any disagreement with Columbia Financial or Columbia Bank regarding their operations, policies, or procedures, indicating an orderly and planned board transition rather than a conflict-driven departure.
Columbia Financial, Inc. reported an insider equity change for SEVP & Chief Risk Officer John Klimowich. On February 6, 2026, 36.9665 phantom shares of common stock at $18.52 were purchased on a non-discretionary basis by the trustee of the bank’s rabbi trust under a stock-based deferral plan and credited to his account.
Following this transaction, he beneficially held 8,262.7158 common-stock-denominated units through the Stock-Based Deferral Plan, along with additional common stock positions held directly and through a 401(k), ESOP, SERP, and stock award programs, plus several tranches of stock options granted under the 2019 Equity Incentive Plan.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported an indirect acquisition of 100.3072 shares of Common Stock on February 6, 2026 at $18.52 per share. The amount reflects phantom stock purchased on a non-discretionary basis in a stock-based deferral plan.
These stock unit interests in the Columbia Bank Stock Based Deferral Plan will be settled in shares of Columbia Financial stock when distributed to Mr. Kemly. The filing also lists his existing direct and indirect holdings of common stock, 401(k), ESOP, SERP, stock awards, and multiple stock option grants.
Columbia Financial, Inc. director Daria Stacy-Walls Torres reported an automatic acquisition of phantom stock tied to company shares. On February 6, 2026, 263.2289 common-share-equivalent units were purchased at $18.52 each through the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. These stock unit interests will be settled in shares of stock upon distribution to her. Following this transaction, she indirectly held 28,053.9937 common-share-equivalent units through the deferral plan, in addition to 8,048 common shares held directly and 3,207 common shares held indirectly via a Stock Award IV grant that vests on March 11, 2026.
Columbia Financial, Inc. director Noel R. Holland reported an automatic credit of 9.2019 phantom stock units of common stock on February 6, 2026 at $18.52 per unit under the Columbia Bank Stock Based Deferral Plan, bringing his deferral plan balance to 10,020.9401 units.
He also reports holdings of 33,519 shares of common stock directly, 46,280 shares indirectly through a SEP-IRA, and 3,207 shares indirectly through Stock Award IV, which was granted under the 2019 Equity Incentive Plan and vests on March 11, 2026. In addition, he holds 83,294 fully vested stock options exercisable for common stock, expiring on July 23, 2029.